Effects of a selection of histone deacetylase inhibitors on mast cell activation and airway and colonic smooth muscle contraction

International Immunopharmacology

Volumn 8, Issue 13-14, 2008, Pages 1793-1801

  Assem, El Sayed K ^a   Peh, Kheng H ^a   Wan, Beatrice Y C ^a   Middleton, Brian J ^a   Dines, Jon ^a   Marson, Charles M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anti inflammatory; Antigen induced smooth muscle contraction; Guinea pig and rat; Histone deacetylase inhibitors; Mast cell histamine release; Trachea and colon

Indexed keywords

ANTIINFLAMMATORY AGENT; BUTYRIC ACID; CARBACHOL; FLUORIDE SODIUM; G PROTEIN COUPLED RECEPTOR; HISTAMINE; HISTONE DEACETYLASE INHIBITOR; IMMUNOGLOBULIN E ANTIBODY; N (2 AMINOPHENYL) 4 [4 (3 PYRIDINYL) 2 PYRIMIDINYLAMINOMETHYL]BENZAMIDE; PEROXY RADICAL; POTASSIUM CHLORIDE; SEROTONIN; VALPROIC ACID; VORINOSTAT;

AIRWAY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; COLON; CONTROLLED STUDY; DRUG EFFECT; GUINEA PIG; HISTAMINE RELEASE; MALE; MAST CELL; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SWINE; TRACHEA;

ANIMALS; BENZAMIDES; CARBACHOL; CHOLINERGIC AGONISTS; COLON; GUINEA PIGS; HISTAMINE; HISTAMINE AGONISTS; HISTAMINE RELEASE; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; MALE; MAST CELLS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; TRACHEA;

EID: 55249095620     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.08.017     Document Type: Article

References (43)

1. Drummond D.C., Noble C.O., Kirpotin D.B., Guo Z.X., Scott G.K., and Benz C.C. Clinical development of histone deacetylase inhibitors as anticancer agents. Ann Rev Pharmacol Toxicol 45 (2005) 495-528
2. Blanchard F., and Chipoy C. Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases. Drug Discov Today 10 (2005) 197-204
3. Adcock I.M. HDAC inhibitors as anti-inflammatory agents. Br J Pharmacol 150 (2007) 829-831
4. Mishra N., Reilly C.M., Brown D.R., Ruiz P., and Gilkeson G.S. Histone deacetylase inhibitors modulate renal disease in the MRL-Ipr/Ipr mouse. J Clin Invest 111 (2003) 539-552
5. Lin H.S., Hu C.Y., Chan H.Y., Liew Y.Y., Huang H.P., Lepescheux L., Bastianelli E., Baron R., et al. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br J Pharmacol 150 (2007) 862-872
6. Glauben R., Batra A., Fedke I., Zeitz M., Lehr H.A., Leoni F., et al. Histone hyperacetylation is associated with amelioration of experimental colitis in mice. J Immunol 176 (2006) 5015-5022
7. Choi J.H., Oh S.W., Kang M.S., Kwon H.J., Oh G.T., and Kim D.Y. Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 35 (2005) 89-96
8. Lührs H., Gerke T., Müller J.G., Melcher R., Schauber J., Boxberger F., et al. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 37 (2002) 458-466
9. Vernia P., Annese V., Bresci G., d'Albasio G., D'Incà R., Giaccari S., et al. Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest 33 (2003) 244-248
10. Joel S.P., and Marson C.M. Preparation of thiadiazoles and other cyclic compounds as histone deacetylase inhibitors for treating cancer and other diseases. PCT Int Appl (2008) WO 2008047138.
11. Bovingdon M., Assem E.S.K., Wan B.Y.C., Peh K.H., and Pearce F.L. Hydrogen peroxide and the response of trachea of sensitised guinea pigs. Inflamm res 45 Suppl 1 (1996) S7-S8
12. Culbertson S.M., and Porter N.A. Unsymmetrical azo initiators increase efficiency of radical generation in aqueous dispersions, liposomal membranes, and lipoproteins. J Am Chem Soc 122 (2000) 4032-4038
13. Assem E.S.K., Wan B.Y.C., Peh K.H., and Pearce F.L. Effect of PAR-activation on smooth muscle contractile response of guinea-pig trachea and ileum. Inflamm res 53 Suppl 1 (2004) S17-S18
14. Wan B.Y.C., Peh K.H., Pearce F.L., and Assem E.S.K. Effect of genistein on rat ileum smooth muscle contraction and histamine release from rat peritoneal mast cells. Inflamm res 54 Suppl 1 (2005) S9-S10
15. Sagi-Eisenberg R., Foreman J.C., and Shelly R. Histamine release induced by histone and phorbol ester from rat peritoneal mast cells. Eur J Pharmacol 113 (1985) 11-17
16. Shore P.A., Burkhalter A., and Cohn Jr. V.H. A method for the fluorometric assay of histamine in tissues. J Pharmac Exp Therap 127 (1959) 182-186
17. Bailey S.J., and Hourani S.M.0. A study of the purinoceptors mediating contraction in the rat colon. Br J Pharmacol 100 (1990) 753-756
18. Chen L.F., Fischle W., Verdin E., and Greene W.C. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293 (2001) 1653-1657
19. Ashburner B.P., Westerheide S.D., and Baldwin A.S. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21 (2001) 7065-7077
20. Yu Z., Zhang W., and Kone B.C. Histone deacetylases augment cytokine induction of the iNOS gene. J Am Soc Nephrol 13 (2002) 2009-2017
21. Zhong H., May M.J., Jimi E., and Ghosh S. The phosphorylation status of nuclear NF-kappaB determines its association with CBP/p300 or HDAC-1. Mol Cell 9 (2002) 625-636
22. Cosio B.G., Mann B., Ito K., Jazrawi E., Barnes P.J., Chung K.F., et al. Histone acetylase and deacetylase activity in alveolar macrophages and blood monocytes in asthma. Am J Respir Crit Care Med 170 (2004) 141-147
23. Ito K., Ito M., Elliott W.M., Cosio B., Caramori, Kon O.M., et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352 (2005) 1967-1976
24. Ito K., Barnes P.J., and Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 20 (2000) 6891-7903
25. Ito K., Yamamura S., Essilfie-Quaye S., Cosio B., Ito M., Barnes P.J., et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-K{green}B suppression. J Exp Med 203 (2006) 7-13
26. Ito K., Lim S., Caramori G., Cosio B., Chung K.F., Adcock I.M., et al. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci 99 (2002) 8921-8926
27. Spiegelberg B.D., and Hamm H.E. Gβγ binds histone deacetylase 5 (HDAC5) and inhibits its transcriptional co-repression activity. J Biol Chem 280 (2005) 41769-41776
28. Mineo H., Hashizume Y., Hanaki Y., Murata K., Maeda H., and Onaga T. Chemical specificity of short-chain fatty acids in stimulating insulin and glucagon secretion in sheep. Am J Physiol Endocrinol Metab 267 (1994) E 2324-E 2341
29. Dianzani C., Cavalli R., Zara G.P., Gallicchio M., Lombardi G., Gasco M.R., et al. Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells. Br J Pharmacol 148 (2006) 648-656
30. Brown A.J., Goldsworthy S.M., Barnes A.A., Eilert M.M., Tcheang L., Daniels D., et al. The orphan G-protein coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278 (2003) 11312-11319
31. Yonezawa T., Kobayashi Y., and Obara Y. Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer line. Cellular Signalling 19 (2007) 185-193
32. Karaki S.I., Mitsui R., Hayashi H., Kato I., Sugiya H., Iwanaga T., Furness J.B., et al. Short- chain fatty acid receptor, GPR443, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tis Res 324 (2006) 353-360
33. Karaki S.I., Tazoe H., Hayashi H., Kashiwabara H., Tooyama K., Suzuki Y., et al. Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol 39 (2008) 135-142
34. Fukumoto S., Tatewaki M., Yamada T., Fujimiya M., Mantyh C., Voss M., et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am J Physiol Regul Integr Comp Physiol 284 (2003) R1269-1276
35. Carta S., Tassi S., Semino C., Fossati G., Mascagni P., Dinarello C.A., et al. Histone deacetylase inhibitors prevent exocytosis of interleukin-1β-containing secretory lysosomes: role of microtubules. Blood 108 (2006) 1618-1626
36. Diakos C., Prieschl E.E., Säemann M.D., Böhmig G.A., Csonga R., Sobanov Y., et al. n-Butyrate inhibits Jun NH(2)-terminal kinase activation and cytokine transcription in mast cells. Biochem Biophys Res Comm 349 (2006) 863-868
37. Fujihara C.K., Mattar A.L., Vieira Jr. J.M., Malheiros D.M.A.C., Noronha I de L., Gonçalves A.R.R., et al. Evidence for the existence of two distinct functions for the inducible NO synthase in the rat kidney: effect of aminoguanidine in rats with 5/6 ablation. J Am Soc Nephrol 13 (2002) 2278-2287
38. Suuronen T., Huuskonen J., Pihlaja R., Kyrylenko S., and Salminen A. Regulation of microglial inflammatory response by histone deacetylase inhibitors. J Neurochem 87 (2003) 407-416
39. Zhang Y., Li N., Caron C., Matthias G., Hess D., Khochbin S., et al. HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. The EMBO J 22 (2003) 1168-1179
40. Glozak M.A., Sengupta N., Zhang X., and Seto E. Acetylation and deacetylation of non-histone proteins. Gene 363 (2006) 15-23
41. Samstag Y., Eibert S.M., Klemke M., and Wabnitz G.H. Actin cytoskeleton dynamics in T lymphocyte activation and migration. J Leuk Biol 73 (2003) 30-48
42. Miletic A.V., Swat M., Fugjikawa K., and Swat W. Cytoskeletal remodeling in lymphocyte activation. Cur Opinion Immunol 15 (2003) 261-268
43. Waltregny D., Glénisson W., Tran S.L., North B.J., Verdin E., Colige A., et al. Histone deacetylase HDAC8 associates with smooth muscle α-actin and is essential for smooth muscle contractility. The FASEB J 19 (2005) 966-968